Skip to main content

and
  1. Article

    Open Access

    Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation

    Pulmonary hypertension (PH) is a progressive fatal disease with no cure. Canagliflozin (CANA), a novel medication for diabetes, has been found to have remarkable cardiovascular benefits. However, few studies h...

    **u-chun Li, **a-yan Zhu, Yang-yue Wang, Shuo-lan Tong in Acta Pharmacologica Sinica (2024)

  2. Article

    Open Access

    Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse

    Aging is a physiological condition accomplished with persistent low-grade inflammation and metabolic disorders. FGF21 has been reported to act as a potent longevity determinant, involving inflammatory response...

    Lu-Qiong Cai, **u-Chun Li, Yang-Yue Wang, Yu-**n Chen, **a-Yan Zhu in Inflammation (2024)